302 related articles for article (PubMed ID: 9928473)
21. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
22. Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.
Matsuyama A; Shiraishi T; Trapasso F; Kuroki T; Alder H; Mori M; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14988-93. PubMed ID: 14630947
[TBL] [Abstract][Full Text] [Related]
23. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract][Full Text] [Related]
24. FRA3B and other common fragile sites: the weakest links.
Huebner K; Croce CM
Nat Rev Cancer; 2001 Dec; 1(3):214-21. PubMed ID: 11902576
[TBL] [Abstract][Full Text] [Related]
25. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion.
Inoue H; Ishii H; Alder H; Snyder E; Druck T; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14584-9. PubMed ID: 9405656
[TBL] [Abstract][Full Text] [Related]
26. FHITness and cancer.
Druck T; Berk L; Huebner K
Oncol Res; 1998; 10(7):341-5. PubMed ID: 10063967
[TBL] [Abstract][Full Text] [Related]
27. Common fragile sites, extremely large genes, neural development and cancer.
Smith DI; Zhu Y; McAvoy S; Kuhn R
Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
[TBL] [Abstract][Full Text] [Related]
28. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.
Ohta M; Inoue H; Cotticelli MG; Kastury K; Baffa R; Palazzo J; Siprashvili Z; Mori M; McCue P; Druck T; Croce CM; Huebner K
Cell; 1996 Feb; 84(4):587-97. PubMed ID: 8598045
[TBL] [Abstract][Full Text] [Related]
29. Direct correlation between FRA3B expression and cigarette smoking.
Stein CK; Glover TW; Palmer JL; Glisson BS
Genes Chromosomes Cancer; 2002 Jul; 34(3):333-40. PubMed ID: 12007194
[TBL] [Abstract][Full Text] [Related]
30. Roles of FHIT and WWOX fragile genes in cancer.
Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
[TBL] [Abstract][Full Text] [Related]
31. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
[TBL] [Abstract][Full Text] [Related]
32. Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit.
Shiraishi T; Druck T; Mimori K; Flomenberg J; Berk L; Alder H; Miller W; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2001 May; 98(10):5722-7. PubMed ID: 11320209
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of the FHIT gene in human prostate cancer.
Latil A; Bièche I; Fournier G; Cussenot O; Pesche S; Lidereau R
Oncogene; 1998 Apr; 16(14):1863-8. PubMed ID: 9583683
[TBL] [Abstract][Full Text] [Related]
34. A novel approach to simultaneously scan genes at fragile sites.
Willem P; Brown J; Schouten J
BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
[TBL] [Abstract][Full Text] [Related]
35. Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12.
Lott ST; Lovell M; Naylor SL; Killary AM
Cancer Res; 1998 Aug; 58(16):3533-7. PubMed ID: 9721855
[TBL] [Abstract][Full Text] [Related]
36. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
Zanesi N; Pekarsky Y; Croce CM
Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
[TBL] [Abstract][Full Text] [Related]
37. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.
Turner BC; Ottey M; Zimonjic DB; Potoczek M; Hauck WW; Pequignot E; Keck-Waggoner CL; Sevignani C; Aldaz CM; McCue PA; Palazzo J; Huebner K; Popescu NC
Cancer Res; 2002 Jul; 62(14):4054-60. PubMed ID: 12124341
[TBL] [Abstract][Full Text] [Related]
38. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM
Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101
[TBL] [Abstract][Full Text] [Related]
39. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
Mao L; Fan YH; Lotan R; Hong WK
Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845
[TBL] [Abstract][Full Text] [Related]
40. A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints.
Paradee W; Wilke CM; Wang L; Shridhar R; Mullins CM; Hoge A; Glover TW; Smith DI
Genomics; 1996 Jul; 35(1):87-93. PubMed ID: 8661108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
